- Marley Health has launched to develop AI-driven clinical intelligence tools for veterinary medicine.
- The company is combining machine learning from the University of Oxford with clinical research conducted alongside the Royal Veterinary College.
- Its first product will pair a smart collar with veterinary and pet-owner digital platforms to monitor health biomarkers over time.
- Initial biomarkers will include gait, posture, resting heart rate, and respiratory rate.
- Marley says its platform is designed to provide veterinarians with clinically relevant insights rather than raw health data.
Marley Health has launched with the goal of bringing clinical-grade artificial intelligence and biomarker development to companion animal healthcare, positioning its platform as a tool to help veterinarians and pet owners monitor health changes between clinic visits.
The London-based company says it is adapting technologies commonly used in human healthcare—including artificial intelligence, physiological monitoring, and signal processing—to develop validated biomarkers for veterinary medicine.
Built on veterinary and machine learning expertise
Marley Health said its technology combines machine learning expertise from the University of Oxford with clinical studies conducted through the Royal Veterinary College (RVC). The company was founded by leaders with backgrounds spanning Johnson & Johnson, Oxford clinical machine learning, and veterinary medicine.
Its first product will integrate a purpose-built smart collar with companion digital platforms for veterinarians and pet owners. The system is intended to continuously collect health data while translating those measurements into clinically relevant insights.
Initial biomarkers under development include gait, posture, resting heart rate, and respiratory rate, with future work focused on additional physiological indicators that could support earlier disease detection.
Focus on clinically validated insights
Rather than emphasizing consumer wellness metrics, Marley says its platform is being developed around validated veterinary biomarkers and clinical benchmarks designed to support decision-making in practice.
Dr. Amanda Boag, co-founder and chief medical officer, said veterinary professionals need clinically relevant information that has been scientifically validated and can be applied in real-world patient care.
The company plans to begin pilot deployments with veterinary organizations in the United Kingdom to evaluate clinical workflows, user experience, and biomarker validation.
Long-term vision for AI-assisted care
Marley Health says its long-term objective is to create a clinical intelligence platform capable of identifying meaningful health changes over time and supporting more proactive, data-informed veterinary care.
As additional clinical data become available, the company plans to expand beyond foundational biomarkers toward more advanced clinical decision-support capabilities using machine learning and longitudinal health monitoring.
Information sourced from the company’s press release.
